Bioxytran (BIXT) Convertible Debt (2021 - 2026)
Bioxytran (BIXT) reported Convertible Debt of $1.15 million for Q2 2026, up 14.3% from $1.01 million a year earlier and up 3.2% from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Convertible Debt (2021 - 2026) Analysis & Trends
At the end of FY2025, Bioxytran posted Convertible Debt of $1.08 million, up 14.2% from FY2024.
- Convertible Debt has a four-year compound annual growth rate of -16.7% (FY2021 to FY2025).
- By year, Convertible Debt came in at $948,642 in FY2024 (-55.3%), $2.12 million in FY2023 (-7.6%), $2.3 million in FY2022 (+2.2%) and $2.25 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Convertible Debt since Q4 2023.
- Year over year, Convertible Debt has now increased in each of the last six quarters, with an average decline of 2.5% over the last eight quarters.
- The high point for year-over-year Convertible Debt in five years was Q2 2025 (growth of 20.9%); the low point was Q1 2024 (a decline of 61.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.12 million (Q1 2026), $1.08 million (Q4 2025) and $1.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.15 Mn |
| Mar 31, 2026 | 1.12 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 979,799.00 |
| Dec 31, 2024 | 948,642.00 |
| Sep 30, 2024 | 878,352.00 |
| Jun 30, 2024 | 835,507.00 |
| Mar 31, 2024 | 885,978.00 |
| Dec 31, 2023 | 2.12 Mn |
| Sep 30, 2023 | 2.09 Mn |
| Jun 30, 2023 | 2.18 Mn |
| Mar 31, 2023 | 2.31 Mn |
| Dec 31, 2022 | 2.30 Mn |
| Sep 30, 2022 | 2.28 Mn |
| Jun 30, 2022 | 3.75 Mn |
| Dec 31, 2021 | 2.25 Mn |
API Access
Bioxytran Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();